CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Chengda Pharmaceuticals Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Chengda Pharmaceuticals Co Ltd
No. 36
Huanghe Road, Huimin Community, Jiashan
Phone: +86 57384601188p:+86 57384601188 JIAXING, ZHJ  314100  China Ticker: 301201301201

Business Summary
Chengda Pharmaceuticals Co Ltd is a China-based company mainly engaged in customized R&D and production of pharmaceutical intermediates. The Company is also engaged in the production and sales of L-carnitine series products and active pharmaceutical ingredients (APIs). The pharmaceutical intermediate products include NP0805/NP0908, NP1205, NP0806, NP1011/1214, NP1709 and others. The L-carnitine series products are used in the fields of food additives, feed additives and raw materials. The APIs products include Buwaxitan, Vidagliptin, Elagoli and others. The Company's products are exported to the United States, Europe, Japan, Canada, the United Kingdom, Italy and other countries and regions.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board JianliGe 70 5/9/2020 5/9/2020
Chief Financial Officer ChaoFei 44 5/9/2020 5/9/2020
General Manager, Director GangLu 48 5/9/2020 5/9/2020
9 additional Officers and Directors records available in full report.

General Information
Number of Employees: 504 (As of 12/31/2022)
Outstanding Shares: 154,713,824 (As of 11/17/2023)
Shareholders: 14,980
Stock Exchange: SHE
Fax Number: +86 57384185902


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, March 29, 2024